Role of the modulation of CYP1A1 expression and activity in chemoprevention

Journal of Applied Toxicology

Volumn 34, Issue 7, 2014, Pages 743-753

  Badal, S ^a   Delgoda, R ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Aryl hydrocarbon receptor; Aryl hydrocarbons; Cancer; Chemoprevention; CYP1A1

Indexed keywords

AMINOFLAVONE; AURANTIIN; BERGAMOTTIN; CIRSILIOL; COUMARIN DERIVATIVE; CURCUMIN; CYTOCHROME P450 1A1; DELPHINIDIN; DEMETHOXYCURCUMIN; DIHYDROISOCOUMARIN; DIOSMETIN; ERIODICTYOL; EUPATORIN; FLAVONE DERIVATIVE; FLAVONOID; GENKWANIN; HESPERETIN; HESPERIDIN; ISOIMPERATORIN; KAEMPFEROL; MELATONIN; MYRICETIN; NARINGENIN; PELARGONIDIN; PLANT EXTRACT; QUERCETIN; RESVERATROL; RUTOSIDE; SANGUINARINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; CARCINOGEN; PLANT MEDICINAL PRODUCT;

CANCER GROWTH; CARCINOGENESIS; CHARBROILED FOOD; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); COMPUTER MODEL; ENZYME ACTIVITY; EXHAUST GAS; FOOD; FUME; HUMAN; MODULATION; MOUTH SQUAMOUS CELL CARCINOMA; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; LIVER; METABOLISM; TOXICITY;

ANIMALS; CARCINOGENESIS; CARCINOGENS; CHEMOPREVENTION; CLINICAL TRIALS AS TOPIC; CYTOCHROME P-450 CYP1A1; HUMANS; LIVER; PHYTOCHEMICALS; PLANT EXTRACTS; POLYMORPHISM, GENETIC;

EID: 84901633162     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2968     Document Type: Review

References (133)

1. Ahmad S, Arjumand W, Seth A, Nafees S, Rashid S, Ali N, Hamiza O, Sultana S. 2012. Risk of Renal Cell Carcinoma and Polymorphism in Phase I Xenobiotic Metabolizing Cyp1a1 and Cyp2d6 Enzymes. Urol. Oncol. 31:1350-1357.
2. Androutsopoulos V, Papakyriakou A, Vourloumis D, Spandidos D. 2011. Comparative Cyp1a1 and Cyp1b1 Substrate and Inhibitor Profile of Dietary Flavonoids. Bioorg. Med. Chem. 19:2842-2849.
3. Androutsopoulos V, Tsatsakis A, Spandidos D. 2009. Cytochrome P450 Cyp1a1: Wider Roles in Cancer Progression and Prevention. Biomed. Central Cancer 9:187-204.
4. Arnold C, Konkel A, Fischer R, Schunck W. 2010. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacol. Rep. 62:536-547.
5. Badal S, Gallimore W, Huang G, Tzeng T, Delgoda R. 2012. Cytotoxic and Potent Cyp1 Inhibitors from the Marine Algae Cymopolia Barbata. Org. Med. Chem. Lett. 2:21-29.
6. Badal S, Williams S, Huang G, Francis S, Vendantam P, Dunbar O, Jacobs H, Tzeng T, Gangemi J, Delgoda R. 2011. Cytochrome P450 1 enzyme inhibition and anticancer potential of chromene amides from Amyris plumieri. Fitoterapia 82:230-236.
7. Beedanagari S, Bebenek I, Bui P, Hankinson O. 2009. Resveratrol Inhibits dioxin-induced expression of human Cyp1a1 and Cyp1b1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and rna polymerase ii to the regulatory regions of the corresponding genes. Toxicol. Sci. 110:61-67.
8. Berge G, Øvrebø S, Eilertsen E, Haugen A, Mollerup S. 2004. Analysis of resveratrol as a lung cancer chemopreventive agent in a/J Mice Exposed to Benzo[a]Pyrene. Br. J. Cancer 91:1380-1383.
9. Bhattacharyya S, Paul S, Dutta S, Boujedaini N, Khuda-Bukhsh A. 2010. Anti-Oncogenic Potentials of a Plant Coumarin (7-Hydroxy-6-Methoxy Coumarin) against 7, 12-Dimethylbenz [a] Anthracene-Induced Skin Papilloma in Mice: The Possible Role of Several Key Signal Proteins. Zhong Xi Yi Jie He Xue Bao 8:645-654.
10. Bock K, Köhle C. 2005. Ah Receptor: Dioxin-Mediated Toxic Responses as Hints to Deregulated Physiologic Functions. Biochem. Pharmacol. 72:393-404.
11. Bourrié M, Meunier V, Berger Y, Fabre G. 1996. Cytochrome P450 Isoform Inhibitors as a Tool for the Investigation of Metabolic Reactions Catalyzed by Human Liver Microsomes. JPET 277:321-331.
12. Buterin T, Hess M, Luneva N, Geacintov N, Amin S, Kroth H, Seidel A, Naegeli H. 2000. Unrepaired Fjord Region Polycyclic Aromatic Hydrocarbon-DNA Adducts in Ras Codon 61 Mutational Hot Spots. Cancer Res. 60:1849-1856.
13. Callero M, Suárez G, Luzzani G, Itkin B, Nguyen B, Loaiza-Perez A. 2012. Aryl Hydrocarbon Receptor Activation by Aminoflavone: New Molecular Target for Renal Cancer Treatment. Int. J. Oncol. 41:125-134.
14. Chabner B. 1991.Anti-Cancer Drugs, Principles and Practice, 4th edn. Lippincott: Philadelphia, PA.
15. Chabner B, Allegra C, Curt G, Calabresi P. 1996. Antineoplastic agents. In The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE (eds). McGraw-Hill: New York, NY. 1233-1287.
16. Chang H, Chen H, Tung H, Liu K, Tsai C, Lii C. 2010. Butein up-Regulates the Expression of the Pi Class of Glutathione S-Transferase in Rat Primary Hepatocytes through the Erk/Ap-1 Pathway. J. Agric. Food Chem. 58:8994-9000.
17. Chang T, Chen J, Yeung E. 2006. Effect of Ginkgo Biloba Extract on Procarcinogen-Bioactivating Human Cyp1 Enzymes: Identification of Isorhamnetin, Kaempferol, and Quercetin as Potent Inhibitors of Cyp1b1. Toxicol. Appl. Pharmacol. 213:18-26.
18. Chen H, Perdew G. 1994. Subunit Composition of the Heteromeric Cytosolic Aryl Hydrocarbon Receptor Complex. J. Biol. Chem. 269:27554-27558.
19. Cheng S, Hilton B, Roman J, Dipple A. 1989. DNA Adducts from Carcinogenic and Noncarcinogenic Enantiomers of Benzo[a]Pyrene Dihydrodiol Epoxide. Chem. Res. Toxicol. 2:334-340.
20. Choi D, Lee J, Kim M, Woo E, Kim Y, Kang K. 2005. Chrysoeriol Potently Inhibits the Induction of Nitric Oxide Synthase by Blocking Ap-1 Activation. J. Biomed. Sci. 12:949-959.
21. Chun Y, Kim M, Guengerich F. 1999. Resveratrol Is a Selective Human Cytochrome P450 1a1 Inhibitor. Biochem. Biophys. Res. Commun. 19:20-24.
22. Ciolino H, Daschner P, Wang T, Yeh G. 1998a. Effect of Curcumin on the Aryl Hydrocarbon Receptor and Cytochrome P450 1a1 in Mcf-7 Human Breast Carcinoma Cells. Biochem. Pharmacol. 15:197-206.
23. Ciolino H, Daschner P, Yeh G. 1998b. Resveratrol Inhibits Transcription of Cyp1a1 in Vitro by Preventing Activation of the Aryl Hydrocarbon Receptor. Cancer Res. 58:5707-5712.
24. Ciolino HP, Daschner PJ, Yeh GC. 1999. Dietary Flavonols Quercetin and Kaempferol Are Ligands of the Aryl Hydrocarbon Receptor That Affect Cyp1a1 Transcription Differentially. Biochem. J. 340:715-722.
25. Ciolino H, Yeh G. 1999. The Flavonoid Galangin Is an Inhibitor of Cyp1a1 Activity and an Agonist/Antagonist of the Aryl Hydrocarbon Receptor. Br. J. Cancer 79:1340-1346.
26. Coon M, Vaz A, Bestervelt L. 1996. Peroxidative Reactions of Diversozymes. FASEB J. 10:428-434.
27. Cox M, Miller C. 2004. Cooperation of Heat Shock Protein 90 and p23 in Aryl Hydrocarbon Receptor Signaling. Cell Stress Chaperones 9: 4-20.
28. Crofford L, Lipsky P, Brooks P, Abramson S, Simon L, van de Putte L. 2000. Basic Biology and Clinical Application of Specific Cyclooxygenase-2 Inhibitors. Arthritis Rheum. 43:4-13.
29. Crofts F, Taioli E, Trachman J, Cosma G, Currie D, Toniolo P, Garte S. 1994. Functional Significance of Different Human Cyp1a1 Genotypes. Carcinogenesis 15:2961-2963.
30. Ding X, Kaminsky L. 2003. Human Extrahepatic Ctyochrome P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts. Annu. Rev. Pharmacol. Toxicol. 43:149-173.
31. Doostdar H, Burke M, Mayer R. 2000. Bioflavonoids: Selective Substrates and Inhibitors for Cytochrome P450 Cyp1a and Cyp1b1. Toxicology 144:31-38.
32. Easton D, Ford D, Bishop D. 1995. Breast and Ovarian Cancer Incidence in Brca1-Mutation Carriers. Am. J. Hum. Genet. 56:265-271.
33. El Gendy M, Soshilov A, Denison M, El-Kadi A. 2012. Transcriptional and Posttranslational Inhibition of Dioxin-Mediated Induction of Cyp1a1 by Harmine and Harmol. Toxicol. Lett. 208:51-61.
34. Endringer D, Guimarães K, Kondratyuk T, Pezzuto J, Braga F. 2008. Selective Inhibition of Aromatase by a Dihydroisocoumarin from Xyris Pterygoblephara. J. Nat. Prod. 71:1082-1084.
35. Ford D, Easton D, Bishop D, Narod S, Goldgar D. 1994. Risk of Cancer in Brca1-Mutation Carriers. Lancet 343:696-695.
36. Ford D, Easton D, Stratton M, Narod S, Goldgar D, Devilee P, Bishop D, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare M, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck T, Tonin P, Neuhausen S, Barkardottir R, Eyfjörd J, Lynch H, Ponder B, Gayther S, Birch J, Lindblom A, Stoppa-Lyonnet D, Bignon Y-J, Borg Å, Hamann U, Haites N, Scott R, Maugard C, Vasen H, Seitz S, Cannon-Albright L, Schofield A, Zelada-Hedman M. 1998. Genetic Heterogeneity and Penetrance Analysis of the Brca1 and Brca2 Genes in Breast Cancer Families. Am. J. Hum. Genet. 62:676-689.
37. Guarrera S, Sacerdote C, Fiorini L, Marsala R, Polidoro S, Gamberini S, Saletta F, Malaveille C, Talaska G, Vineis P, Matullo G. 2007. Expression of DNA Repair and Metabolic Genes in Response to a Flavonoid-Rich Diet. Br. J. Nutr. 98:525-533.
38. Hainaut P, Pfeifer G. 2001. Patterns of P53 G-->T Transversions in Lung Cancers Reflect the Primary Mutagenic Signature of DNA-Damage by Tobacco Smoke. Carcinogenesis 22:367-374.
39. Hakkak R, Korourian S, Shelnutt S, Lensing S, Ronis M, Badger T. 2000. Diets Containing Whey Proteins or Soy Protein Isolate Protect against 7, 12-Dimethylbenz(a)Anthracene-Induced Mammary Tumors in Female Rats. Cancer Epidemiol. Biomarkers Prev. 9:113-117.
40. Hamid A, Umbas R, Mochtar C. 2011. Recent Role of Inflammation in Prostate Diseases: Chemoprevention Development Opportunity. Acta Med. Indones-Indones J. Intern. Med. 43:59-65.
41. Hari Kumar K, Kuttan R. 2006. Inhibition of Drug Metabolizing Enzymes (Cytochrome P450) in Vitro as Well as in Vivo by Phyllanthus Amarus Schum & Thonn. Biol. Pharm. Bull. 29:1310-1313.
42. Hartwell L, Kastan M. 1994. Cell Cycle Control and Cancer. Science 266:1821-1828
43. Hasler J, Estabrook R, Murray M, Pikuleva I, Waterman M, Capdevila J, Holla V, Helvig C, Falck J, Farrell G, Kaminsky L, Spivack S, Boitier E, Beaune P. 1999. Cytochrome P450. Mol. Aspects Med. 20:1-137.
44. Hecht S. 1999. Tobacco Smoke Carcinogens and Lung Cancer. J. Natl. Cancer Inst. 91:1194-1210.
45. Herraiz T, Gonzalez D, Ancin-Azpilicueta C, Aran V, Guillen H. 2010. Beta-Carboline Alkaloids in Peganum Harmala and Inhibition of Human Monoamine Oxidase (Mao). Food Chem. Toxicol. 48:839-845.
46. Hughes D, Guttenplan J, Marcus C, Subbaramaiah K, Dannenberg A. 2008. Heat Shock Protein 90 Inhibitors Suppress Aryl Hydrocarbon Receptor-Mediated Activation of Cyp1a1 and Cyp1b1 Transcription and DNA Adduct Formation. Cancer Prev. Res. 1:485-493.
47. IARC. 2010. Agents Classified by the Iarc Monographs 2010 [cited 1-100].http://monographs.iarc.fr/ENG/Classification/ClassificationsAlphaOrder.pdf.
48. Kainu T, Juo S, Desper R, Chäfferm A, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi O. 2000. Somatic Deletions in Hereditary Breast Cancers Implicate 13q21 as a Putative Novel Breast Cancer Susceptibility Locus. Proc. Natl. Acad. Sci. U. S. A. 97:9603-9608.
49. Kamenickova A, Anzenbacherova E, Pavek P, Soshilov A, Denison M, Anzenbacher P, Dvorak Z. 2013. Pelargonidin Activates the Ahr and Induces Cyp1a1 in Primary Human Hepatocytes and Human Cancer Cell Lines Hepg2 and Ls174t. Toxicol. Lett. 218:253-259.
50. Kessler FK, Ritter J. 1997. Induction of a Rat Liver Benzo[a]Pyrene-Trans-7, 8-Dihydrodiol Glucuronidating Activity by Oltipraz and Beta-Naphthoflavone. Carcinogenesis 18:107-114.
51. Khan A, Gilani A. 2006. Selective Bronchodilatory Effect of Rooibos Tea (Aspalathus Linearis) and Its Flavonoid, Chrysoeriol. Eur. J. Nutr. 45:463-469.
52. Kim J, Stansbury K, Walker N, Trush M, Strickland P, Sutter T. 1998. Metabolism of Benzo[a]Pyrene and Benzo[a]Pyrene-7, 8-Diol by Human Cytochrome P450 1b1. Carcinogenesis 19:1847-1853.
53. Kiruthiga P, Karthikeyan K, Archunan G, Karutha Pandian S, Pandima Devi K. 2013. Silymarin Prevents Benzo(a)Pyrene-Induced Toxicity in Wistar Rats by Modulating Xenobiotic-Metabolizing Enzymes. Toxicol. Ind. Health. DOI: 10.1177/0748233713475524.
54. Klassenn D(ed), 2001. Casarette and Doull's Toxicology: The Basic Science of Poisons, 6th edn. McGraw-Hill: New York, U.S.A. 107-367.
55. Koreeda M, Moore P, Yagi H, Yeh H, Jerina D. 1976. Alkylation of Polyguanylic Acid at the 2-Amino Group and Phosphate by the Potent Mutagen (-7â, 8r-Dihydroxy-9â, 10â-Epoxy-7, 8, 9, 10-Tetrahydrobenzo[a]Pyrene. J. Am. Chem. Soc. 98:6720-6722.
56. Lee A, Cai M, Thomas P, Conney A, Zhu B. 2003. Characterization of the Oxidative Metabolites of 17beta-Estradiol and Estrone Formed By15 Selectively Expressed Human Cytochrome P450 Isoforms. Endocrinology 144:338-3398.
57. Lee J, Safe S. 2000. 3′, 4′-Dimethoxyflavone as an Aryl Hydrocarbon Receptor Antagonist in Human Breast Cancer Cells. Toxicol. Sci. 58:235-242.
58. Lee S, Kim Y, Kim M, Chun Y, Kim S. 2004. Potent Inhibition of Recombinant Human Cytochrome P-450 1a1 by Pentamethoxystilbene. J. Toxicol. Environ. Health A 67:1987-2000.
59. Letchoumy P, Mohan K, Stegeman J, Gelboin H, Hara Y, Nagini S. 2008. In Vitro Antioxidative Potential of Lactoferrin and Black Tea Polyphenols and Protective Effects in Vivo on Carcinogen Activation, DNA Damage, Proliferation, Invasion, and Angiogenesis During Experimental Oral Carcinogenesis. Oncol. Res. 17:193-203.
60. Leung H, Wang Y, Chan H, Leung L. 2007. Developing a High Throughput System for the Screening of Cytochrome P450 1a1 - Inhibitory Polyphenols. Toxicol. In Vitro 21:996-1002.
61. Lewis B, Mackenzie P, Miners J. 2007a. Comparative Homology Modeling of Human Cytochrome P4501a1 (Cyp1a1) and Confirmation of Residues Involved in 7-Ethoxyresorufin O-Deethylation by Site-Directed Mutagenesis and Enzyme Kinetic Analysis. Arch. Biochem. Biophys. 468:58-69.
62. Lewis BC, Mackenzie PI, Miners JO. 2007b. Comparative Homology Modeling of Human Cytochrome P4501a1 (Cyp1a1) and Confirmation of Residues Involved in 7-Ethoxyresorufin O-Deethylation by Site-Directed Mutagenesis and Enzyme Kinetic Analysis. Arch. Biochem. Biophys. 468:58-69.
63. Li Y, Zhao M, Parkin K. 2011. Β-Carboline Derivatives and Diphenols from Soy Sauce Are in Vitro Quinone Reductase (Qr) Inducers. J. Agric. Food Chem. 59:2332-2340.
64. Lin L, Lu S, Harnly J. 2007. Detection and Quantification of Glycosylated Flavonoid Malonates in Celery, Chinese Celery, and Celery Seed by Lc-Dad-Esi/Ms. J. Agric. Food Chem. 55:1321-1326.
65. Liu J, Nguyen T, Dupart P, Sridhar J, Zhang X, Zhu N, Stevens C, Foroozesh M. 2012. 7-Ethynylcoumarins: Selective Inhibitors of Human Cytochrome P450s 1a1 and 1a2. Chem. Res. Toxicol. 25:1047-1057.
66. Ma X, Idle JR, Malfatti MA, Krausz KW, Nebert DW, Chen CS, Felton JS, Waxman DJ, Gonzalez FJ. 2007. Mouse Lung Cyp1a1 Catalyzes the Metabolic Activation of 2-Amino-1-Methyl-6-Phenylimidazo[4, 5-B]Pyridine (Phip). Carcinogenesis 28:732-737.
67. Ma X, Idle J, Krausz K, Gonzalez F. 2005. Metabolism of Melatonin by Human Cytochromes P450. Drug Metab. Dispos. 33:489-494.
68. MacDonald C, Ciolino H, Yeh G. 2001. Dibenzoylmethane Modulates Aryl Hydrocardon Receptor Function and Expression of Cytochromes P450 1a1, 1a2 and 1b1. Cancer Res. 61:3919-3924.
69. McLemore T, Adelberg S, Liu M, McMahon N, Yu S, Hubbard W. 1990. Expression of Cyp1a1 Gene in Patients with Lung Cancer: Evidence for Cigarette Smoke-Induced Gene Expression in Normal Lung Tissue and for Altered Gene Regulation in Primary Pulmonary Carcinomas. J. Natl. Cancer 82:1333-1339.
70. Meyer B, Pray-Grant M, Vanden Heuvel J, Perdew G. 1998. Hepatitis B Virus X-Associated Protein 2 Is a Subunit of the Unliganded Aryl Hydrocarbon Receptor Core Complex and Exhibits Transcriptional Enhancer Activity. Mol. Cell. Biol. 18:978-988.
71. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W. 1994. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene Brca1. Science 266:66-71.
72. Mikstacka R, Przybylska D, Rimando A, Baer-Dubowska W. 2007. Inhibition of Human Recombinant Cytochromes P450 Cyp1a1 and Cyp1b1 by Trans-Resveratrol Methyl Ethers. Mol. Nutr. Food Res. 51:517-524.
73. Mohammadi-Bardbori A, Bengtsson J, Rannug U, Rannug A, Wincent E. 2012. Quercetin, Resveratrol, and Curcumin Are Indirect Activators of the Aryl Hydrocarbon Receptor (Ahr). Chem. Res. Toxicol. 17:1878-1884.
74. Mohebati A, Guttenplan J, Kochhar A, Zhao Z, Kosinska W, Subbaramaiah K, Dannenberg A. 2012. Carnosol, a Constituent of Zyflamend, Inhibits Aryl Hydrocarbon Receptor-Mediated Activation of Cyp1a1 and Cyp1b1 Transcription and Mutagenesis. Cancer Prev. Res. 5:593-602.
75. Morffi J, Rodeiro I, Hernández S, González L, Herrera J, Espinosa-Aguirre J. 2012. Antimutagenic Properties of Mangifera Indica L. Stem Bark Extract and Evaluation of Its Effects on Hepatic Cyp1a1. Plant Foods Hum. Nutr. 67:223-228.
76. Naderi-Kalali B, Allameh A, Rasaee M, Bach H, Behechti A, Doods K, Kettrup A, Schramm K. 2005. Suppressive Effects of Caraway (Carum Carvi) Extracts on 2, 3, 7, 8-Tetrachloro-Dibenzo-P-Dioxin-Dependent Gene Expression of Cytochrome P450 1a1 in the Rat H4iie Cells. Toxicol. In Vitro 19:373-377.
77. Nebert D, Dalton T, Okey A, Gonzalez F. 2004. Role of Aryl Hydrocarbon Receptor-Mediated Induction of the Cyp1 Enzymes in Environmental Toxicity and Cancer. J. Biol. Chem. 279:23847-23850.
78. Nelson D, Koymans L, Kamataki T, Stegeman J, Feyereisen R, Waxman D, Waterman M, Gotoh O, Coon M, Estabrook R, Gunsalus I, Nebert D. 1996. P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers and Nomenclature. Pharmacogenetics 6:1-42.
79. Norbury C, Nurse P. 1992. Animal Cell Cycles and Their Control. Annu. Rev. Biochem. 61:441-470.
80. Nurse P, Masui Y, Hartwell L. 1998. Understanding the Cell Cycle. Nat. Med. 4:1103-1106.
81. Ohno M, Sakamoto K, Ishizuka M, Fujita S. 2009. Crude Cacao Theobroma Cacao Extract Reduces Mutagenicity Induced by Benzo[a]Pyrene through Inhibition of Cyp1a Activity in Vitro. Phytother. Res. 23:1131-1139.
82. Okino S, Quatrocchi L, Pookot D, Iwahashi M, Dahiya R. 2007. A Dioxin-Responsive Enhancer 3′ of the Human Cyp1a2 Gene. Mol. Pharmacol. 72:1457-1465.
83. Olguín-Reyes S, Camacho-Carranza R, Hernández-Ojeda S, Elinos-Baez M, Espinosa-Aguirre J. 2012. Bergamottin Is a Competitive Inhibitor of Cyp1a1 and Is Antimutagenic in the Ames Test. Food Chem. Toxicol. 50:3094-3099.
84. Ozkarsli M, Sevim H, Sen A. 2008. In Vivo Effects of Urtica Urens (Dwarf Nettle) on the Expression of Cyp1a in Control and 3-Methylcholanthrene-Exposed Rats. Xenobiotica 38:48-61.
85. Pfeifer G, Denissenko M, Olivier M, Tretyakova N, Hecht S, Hainaut P. 2002. Tobacco Smoke Carcinogens, DNA Damage and P53 Mutations in Smoking-Associated Cancers. Oncogene 21:7435-7451.
86. Phelan D, Winter G, Rogers W, Lam J, Denison M. 1998. Activation of the Ah Receptor Signal Transduction Pathway by Bilirubin and Biliverdin. Arch. Biochem. Biophys. 357:155-163.
87. Piver B, Berthou F, Dreano Y, Lucas D. 2003. Differential Inhibition of Human Cytochrome P450 Enzymes by Epsilon-Viniferin, the Dimer of Resveratrol: Comparison with Resveratrol and Polyphenols from Alcoholized Beverages. Life Sci. 18:1199-1213.
88. Pokharel Y, Han E, Kim J, Oh S, Kim S, Woo E, Jeong H, Kang K. 2006. Potent Protective Effect of Isoimperatorin against Aflatoxin B1-Inducible Cytotoxicity in H4iie Cells: Bifunctional Effects on Glutathione S-Transferase and Cyp1a. Carcinogenesis 27:2483-2490.
89. Qin G, Meng Z. 2005. Effect of Sulfur Dioxide Inhalation on Cyp1a1 and Cyp1a2 in Rat Liver and Lung. Toxicol. Lett. 160:34-42.
90. Reiners JJ, Lee J, Clift R, Dudley D, Myrand S. 1998. Pd98059 Is an Equipotent Antagonist of the Aryl Hydrocarbon Receptor and Inhibitor of Mitogen-Activated Protein Kinase Kinase. Mol. Pharmacol. 53:438-445.
91. Revel A, Raanani H, Younglai E, Xu J, Rogers I, Han R, Savouret J, Casper R. 2003. Resveratrol, a Natural Aryl Hydrocarbon Receptor Antagonist, Protects Lung from DNA Damage and Apoptosis Caused by Benzo[a]Pyrene. J. Appl. Toxicol. 23:255-261.
92. Rinaldi A, Morse M, Fields H, Rothas D, Ping P, Rodrigo K, Renner R, Mallery S. 2002. Curcumin Activates the Aryl Hydrocarbon Receptor yet Significantly Inhibits (-)-Benzo(a)Pyrene-7r-Trans-7, 8-Dihydrodiol Bioactivation in Oral Squamous Cell Carcinoma Cells and Oral Mucosa. Cancer Res. 62:5451-5456.
93. Rodeiro I, Donato M, Jimenez N, Garrido G, Molina-Torres J, Menendez R, Castell J, Gómez-Lechón M. 2009. Inhibition of Human P450 Enzymes by Natural Extracts Used in Traditional Medicine. Phytother. Res. 23:279-282.
94. Rojas M, Marie B, Vignaud J, Martinet N, Siat J, Grosdidier G, Cascorbi I, Alexandrov K. 2004. High DNA Damage by Benzo[a]Pyrene 7, 8-Diol-9, 10-Epoxide in Bronchial Epithelial Cells from Patients with Lung Cancer: Comparison with Lung Parenchyma. Cancer Lett. 207:157-163.
95. Rowlands J, He L, Hakkak R, Ronis M, Badger T. 2001. Soy and Whey Proteins Downregulate Dmba-Induced Liver and Mammary Gland Cyp1 Expression in Female Rats. J. Nutr. 131:3281-3287.
96. Rushmore T, King R, Paulson K, Pickett C. 1990. Regulation of Glutathione S-Transferase Ya Subunit Gene Expression: Identification of a Unique Xenobiotic-Responsive Element Controlling Inducible Expression by Planar Aromatic Compounds. Proc. Natl. Acad. Sci. U. S. A. 87:3826-3830.
97. Russo J, Lareef M, Balogh G, Guo S, Russo I. 2003. Estrogen and Its Metabolites Are Carcinogenic Agents in Human Breast Epithelial Cells. J. Steroid Biochem. Mol. Biol. 87:1-25.
98. Sadar M, Westlind A, Blomstrand F, Andersson T. 1996. Induction of Cyp1a1 by Gaba Receptor Ligands. Biochem. Biophys. Res. Commun. 229:231-237.
99. Samoylenko V, Rahman M, Tekwani B, Tripathi L, Wang Y, Khan S, Khan I, Miller L, Joshi V, Muhammad I. 2010. Banisteriopsis Caapi, a Unique Combination of Mao Inhibitory and Antioxidative Constituents for the Activities Relevant to Neurodegenerative Disorders and Parkinson's Disease. J. Ethnopharmacol. 127:357-367.
100. Sansen S, Yano J, Reynald R, Schoch G, Griffin K, Stout C, Johnson E. 2007. Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1a2. J. Biol. Chem. 11:14348-14355.
101. Schiltz M, Cui X, Lu Y, Yagi H, Jerina D, Zdzienicka M, Chang R, Conney A, Wei S. 1999. Characterization of the Mutational Profile of (+)-7r, 8s-Dihydroxy-9s, 10r-Epoxy-7, 8, 9, 10-Tetrahydrobenzo[a]Pyrene at the Hypoxanthine (Guanine) Phosphoribosyltransferase Gene in Repair-Deficient Chinese Hamster V-H1 Cells. Carcinogenesis 20:2279-2286.
102. Schwartz G, Shah M. 2005. Targeting the Cell Cycle: A New Approach to Cancer Therapy. J. Clin. Oncol. 23:9408-9421.
103. Schwarz D, Kisselev P, Ericksen S, Szklarz G, Chernogolov A, Honeck H, Schunck W, Roots I. 2004. Arachidonic and Eicosapentaenoic Acid Metabolism by Human Cyp1a1: Highly Stereoselective Formation of 17(R), 18(S)-Epoxyeicosatetraenoic Acid. Biochem. Pharmacol. 67:1445-1457.
104. Schwarz D, Kisselev P, Roots I. 2003. St. John's Wort Extracts and Some of Their Constituents Potently Inhibit Ultimate Carcinogen Formation from Benzo[a]Pyrene-7, 8-Dihydrodiol by Human Cyp1a1. Cancer Res. 15:8062-8068.
105. Schwarz D, Roots I. 2003. In Vitro Assessment of Inhibition by Natural Polyphenols of Metabolic Activation of Procarcinogens by Human Cyp1a1. Biochem. Biophys. Res. Commun. 303:902-907.
106. Seitz S, Rohde K, Bender E, Nothnagel A, Kölble K, Schlag PM, Scherneck S. 1997. Strong Indication for a Breast Cancer Susceptibility Gene on Chromosome 8p12-P22: Linkage Analysis in German Breast Cancer Families. Oncogene 14:741-743.
107. Shields M, Niazi U, Badal S, Yee T, Sutcliffe M, Delgoda R. 2009. Inhibition of Cyp1a1 by Quassinoids Found in Picrasma Excelsa. Planta Med. 75:137-141.
108. Shimada T, Guengerich F. 1989. Evidence for Cytochrome P-450nf, the Nifedipine 31. Oxidase, Being the Principal Enzyme Involved in the Bioactivation of Aflatoxins in Human Liver. Proc. Natl. Acad. Sci. U. S. A. 86:462-465.
109. Shimada T, Martin M, Pruess-Schwanz D, Mamen L, Guengerich F. 1989. Roles of Individual Human Cytochrome P-450 Enzymes in the Bioactivation of Benzo[a]Pyrene, 7, 8-Dihydroxy-7, 8-Dihydrobenzo[a]Pyrene. And Other Dihydrodiol Derivatives of Polycyclic Aromatic Hydrocarbons. Cancer Res. 49:6304-6312.
110. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikaw T. 2000. Benzo[a]Pyrene Carcinogenicity Is Lost in Mice Lacking the Aryl Hydrocarbon Receptor. Proc. Natl. Acad. Sci. U. S. A. 97:779-782.
111. Shukla R, Liu T, Geacintov N, Loechler E. 1997. The Major, N2-Dg Adduct of (+)-Anti-B[a]Pde Shows a Dramatically Different Mutagenic Specificity (Predominantly, G→a) in a 5′-Cgt-3′ Sequence Context. Biochemistry 36:10256-10261.
112. Singhal R, Shankar K, Badger T, Ronis M. 2008. Estrogenic Status Modulates Aryl Hydrocarbon Receptor--Mediated Hepatic Gene Expression and Carcinogenicity. Carcinogenesis 29:227-236.
113. Snijman P, Swanevelder S, Joubert E, Green I, Gelderblom W. 2007. The Antimutagenic Activity of the Major Flavonoids of Rooibos (Aspalathus Linearis): Some Dose-Response Effects on Mutagen Activation-Flavonoid Interactions. Mutat. Res. 28:111-123.
114. Sowers M, McConnell D, Jannausch M, Randolph Jr J, Brook R, Gold E, Crawford S, Lasley B. 2007. Oestrogen Metabolites in Relation to Isoprostanes as a Measure of Oxidative Stress. Clin. Endocrinol. 68:806-813.
115. Stoner G, Morse M, Kelloff G. 1997. Perspectives in Cancer Chemoprevention. Environ. Health Perspect. 105:945-954.
116. Takemura H, Itoh T, Yamamoto K, Sakakibara H, Shimoi K. 2010. Selective Inhibition of Methoxyflavonoids on Human Cyp1b1 Activity. Bioorg. Med. Chem. 18:6310-6315.
117. Tarantini A, Maitre A, Lefebvre E, Marques M, Rajhi A, Douki T. 2011. Polycyclic Aromatic Hydrocarbons in Binary Mixtures Modulate the Efficiency of Benzo[a]Pyrene to Form DNA Adducts in Human Cells. Toxicology 279:36-44.
118. Thapliyal R, Maru G. 2001. Inhibition of Cytochrome P450 Isozymes by Curcumins in Vitro and in Vivo. Food Chem. Toxicol. 39:541-547.
119. Thorlacius S, Struewing J, Hartage P, Olafsdottir G, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjörd J. 1998. Population-Based Study of Risk of Breast Cancer in Carriers of Brca2 Mutation. Lancet 352:1337-1339.
120. Treasure J. 2000. Herbal Pharmacokinetics: A Practitioner Update with Reference to St. Johns Wort (Hypericum Perforatum) Herb-Drug Interactions. MNIMH 1.4:6-7.
121. Vogelstein B, Kinzler K. 2004. Cancer Genes and the Pathways They Control. Nat. Med. 10:789-799.
122. Vrba J, Kosina P, Ulrichová J, Modrianský M. 2004. Involvement of Cytochrome P450 1a in Sanguinarine Detoxication. Toxicol. Lett. 151:375-387.
123. Walsh A, Szklarz GD, Scott E. 2013. Human Cytochrome P450 1a1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism. J. Biol. Chem. 288:12932-12943.
124. Wang Y, Ye X, Ma Z, Liang Q, Lu B, Tan H, Xiao C, Zhang B, Gao Y. 2008. Induction of Cytochrome P450 1a1 Expression by Ginsenoside Rg1 and Rb1 in Hepg2 Cells. Eur. J. Pharmacol. 601:73-78.
125. Wei O, Gu J, Cheng L, Bondy M, Jiang H, Hong W, Spite M. 1996. Benzo (a) Pyrene Diol Epoxide-Induced Chromosomal Aberrations and Risk of Lung Cancer. Cancer Res. 56:3975-3979.
126. Weinstein IB, Jeffrey AM, Jennette KW, Blobstein SH, Harvey RG, Harris C, Autrup H, Kasai H, Nakanishi K. 1976. Benzo[a]Pyrene Diol Epoxides as Intermediates in Nucleic Acid Binding in Vitro and in Vivo. Science 193:92-595.
127. WHO. January 2013. Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/index.html [January 2013].
128. Willey J, Coy E, Frampton M, Torres A, Apostolakos M, Hoehn G, Schuermann W, Thilly W, Olson D, Hammersley J, Crespi C, Utell M. 1997. Quantitative Rt-Pcr Measurement of Cytochromes P450 1a1, 1b1, and 2b7, Microsomal Epoxide Hydrolase, and Nadph Oxidoreductase Expression in Lung Cells of Smokers and Nonsmokers. Am. J. Respir. Cell Mol. Biol. 17:114-124.
129. Williams S, Shiha H, Guenettea D, Brackneyb W, Denisonb M, Pickwella G, Quattrochia L. 2000. Comparative Studies on the Effects of Green Tea Extracts and Individual Tea Catechins on Human Cyp1a Gene Expression. Chem. Biol. Interact. 128:211-229.
130. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. 1996. Identification of the Breast Cancer Susceptibility Gene Brca2. Nature 378:789-792.
131. Yarbro J. 1992. The Scientific Basis of Cancer Chemotherapy, The Chemotherapy Source Book. Williams & Wilkins: Baltimore.
132. Yun J, Lee S, Lee H, Kim C, Kim M, Sohn Y, Nho C. 2010. Bi-Functional Induction of the Quinone Reductase and Cytochrome P450 1a1 by Youngiasides Via Nrf2-Are and Ahr-Xre Pathways. Biol. Pharm. Bull. 33:1650-1657.
133. Zhou C, Li X, Fang W, Yang X, Hu L, Zhou S, Zhou J. 2011. Inhibition of Cyp450 1a and 3a by Berberine in Crucian Carp Carassius Auratus Gibelio. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 154:360-366.